Product Name | Duloxetine HCl |
Description |
5-HT-noradrenaline reuptake inhibitor |
Purity | >98% (TLC); NMR (Conforms) |
CAS No. | 136434-34-9 |
Molecular Formula | C18H19NOS.HCl |
Molecular Weight | 333.9 |
Field of Use | Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only. |
Storage Temperature | -20ºC |
Shipping Temperature | Blue Ice or 4ºC |
Product Type | Inhibitor |
Solubility | May be dissolved in DMSO (30 mg/ml); or water (3 mg/ml) |
Source | Synthetic |
Appearance | White powder |
SMILES | CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32.Cl |
InChI | InChI=1S/C18H19NOS.ClH/c1-19-12-11-17(18-10-5-13-21-18)20-16-9-4-7-14-6-2-3-8-15(14)16;/h2-10,13,17,19H,11-12H2,1H3;1H/t17-;/m0./s1 |
InChIKey | BFFSMCNJSOPUAY-LMOVPXPDSA-N |
Safety Phrases |
WHMIS Classification: Not WHMIS controlled. GHS Classification: Acute toxicity, Oral (Category 4) Signal word: Warning Hazard statement(s): H302 Harmful if swallowed. Precautionary statement(s) none HMIS Classification: Health hazard: 1 Flammability: 0 Physical hazards: 0 Potential Health Effects: Inhalation - May be harmful if inhaled. May cause respiratory tract irritation. Skin - Harmful if absorbed through skin. May cause skin irritation. Eyes - May cause eye irritation. Ingestion - Harmful if swallowed. |
Cite This Product | Duloxetine HCl (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-549) |
Alternative Names | Duloxetine Hydrochloride, (+)-(S)-N-Methyl-3-(1-naphthyloxy)-3-(2-thienyl)propanamine hydrochloride, (S)-Duloxetine hydrochloride, (γS)-N-Methyl-γ-(1-naphthalenyloxy)-2-thiophenepropanamine hydrochloride, (+)-(S)-N-Methyl-γ-(1-naphthyloxy)-2-thiophenepropylamine hydrochloride, (+)-N-Methyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine hydrochloride, (3S)-N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-ylpropan-1-amine;hydrochloride, Duloxetine HCl |
Research Areas | Alpha-2 Adrenergic Receptors, Neuroscience, Neurotransmitter Receptors |
PubChem ID | 60834 |
Reviews
There are no reviews yet.